Equine herpesvirus 1 UL3 gene of EHV-1 Tegument protein of EHV-1 UL3, not essential for EHV-1 virulence The UL3 gene of equine herpesvirus-1 (EHV-1) is retained in the genome of defective interfering particles and encodes a~33 kDa myristylated protein. Further characterization showed that the UL3 gene is trans-activated only by the sole immediate early (IE) protein and encodes an early protein that is dispensable for EHV-1 replication and localizes in the tegument of purified virions. UL3-deleted EHV-1 (vL11ΔUL3) exhibits properties of host cell tropism, plaque size, and growth kinetics similar to those of the parental virus. Expression levels of EHV-1 proteins representative of all three gene classes in vL11ΔUL3-infected cells were identical to those in cells infected with parental virus. Mice intranasally infected with vL11ΔUL3 and parental virus showed no significant difference in mortality or virus lung titers. These findings suggest that the UL3 protein does not play a major role in the biology of EHV-1 in cell culture or virulence in the mouse.
Introduction
Equine herpesvirus-1 (EHV-1) is a member of Genus Varicellovirus, Alphaherpesvirinae, Herpesviridae and possesses a linear double-stranded DNA genome,~150 kbp in length (O'Callaghan and Osterrieder, 2008; Telford et al., 1992) . During lytic replication, the viral gene program of immediate-early, early, and late stages is governed by EHV-1 positive and negative regulatory proteins (Caughman et al., 1985; Gray et al., 1987a, b) . The IE protein (IEP) upregulated by a tegument ETIF protein (ETIFP) (Elliott and O'Hare, 1995) trans-activates early and some late genes (Kim et al., 1997; Smith et al., 1992 Smith et al., , 1994 , and also downregulates its own promoter (Kim et al., 1995) . Early regulatory gene products include the EICP0 protein (IECP0P), IR4 protein (IR4P) and UL5 protein (UL5P) that independently or synergistically with the IEP trans-activate early and late genes (Bowles et al., 2000; Breitenbach et al., 2009; Holden et al., 1995; Smith et al., 1992) . In addition, three early EHV-1 gene products, the IR2 protein (IR2P) Kim et al., 2006) , UL4 protein (UL4P) (Charvat et al., 2011) , and IR3 RNA (Ahn et al., 2007 (Ahn et al., , 2010 , play a role in regulating viral gene expression as negative regulatory molecules.
EHV-1 persistent infection in either cell culture (Henry et al., 1979) or an animal model (Campbell et al., 1976; O'Callaghan et al., 1983 ) is mediated by virus enriched with EHV-1 defective interfering particles (DIP) that have a genome composed of a unique IR4/UL5 hybrid gene, the UL3 and UL4 genes of the parent virus, cleavage and package signals, and an origin of replication (Baumann et al., 1986 (Baumann et al., , 1987 Ebner and O'Callaghan, 2006) . Co-existence of both viruses may be maintained by a mechanism in which the IEP of the standard virus trans-activates the three genes of the DIP genome whose protein products downregulate expression of the IE gene and temper virus gene expression (Chen et al., 1999) . The IR4/UL5 hybrid gene is important in mediating interference with the replication of the standard virus (Ebner et al., 2008) , and more recent work revealed that the UL4 gene encodes an early protein that inhibits gene expression controlled by both viral and heterologous promoters, suggesting the possibility that this non-essential gene contributes to the mechanism of persistent infection (Charvat et al., 2011) . Very little is known about the EHV-1 UL3 gene that is also conserved in the DIP genome. An initial study mapped the 1.2 kb UL3 transcript and identified cis-acting elements such as a tentative TATA box, a 325 nt 5′untranslated region (UTR) , and an open reading frame (ORF) of 258 amino acids . A later report showed that UL3 encodes a~33 kDa myristylated protein that is localized in the perinuclear region of the cytoplasm of infected cells (Harty et al., 1993a) . UL3 homologues are present in varicella-zoster virus as the non-essential ORF2 (Davison and Scott, 1986; Sato et al., 2002) , bovine herpesvirus 1 as the dispensable circ gene (Fraefel et al., 1993 (Fraefel et al., , 1994 Schwyzer et al., 2002) , and Marek's disease virus as ORF71 of unknown function (Izumiya et al., 2001 ), but a UL3 homolog is not present in the genome of herpes simplex viruses 1 or 2. However, it remains unknown how the UL3 gene is regulated, in which stages the UL3 gene is expressed, whether the UL3 protein (UL3P) is a component of the EHV-1 virion, and whether the UL3 gene contributes essential functions for EHV-1 replication and pathogenesis. Here, we Virology 420 (2011) 20-31 
Results

The UL3 gene is trans-activated by the IEP
The promoter sequences of the UL3 gene of RacL11 are different from those of the Ab4 EHV-1 UL3 gene because the RacL11 EHV-1 genome lacks a part of the UL1 gene and an entire UL2 gene as shown in Fig. 1A (Telford et al., 1992; Yalamanchili and O'Callaghan, 1990) . Previous studies (Harty et al., 1993a) showed that the UL3 transcript contains a 325 nt UTR and that the UL3 gene harbors the tentative TATA box sequences at 30-36 nt upstream of the transcription initiation site (Fig. 1B) . To determine how the UL3 gene is regulated, we cloned different regions of the UL3 promoter into the pGL3-basic vector (Fig. 1B) and determined the promoter activity in luciferase reporter assays. Comparison of the UL3 promoter activities revealed that the pUL3(−777/-54)-Luc lacking a tentative TATA box sequence showed no promoter activity (Fig. 1C, bar 4) and that the pUL3(−342/+324)-Luc showed the highest promoter activity (Fig. 1C, bar 3 ) such that this promoter was used for additional assays. To determine which EHV-1 regulatory proteins trans-activate the UL3 gene, co-transfection assays were performed using the pUL3 (−342/+324)-Luc as a reporter vector and plasmids that express EHV-1 regulatory proteins as an effector vector. Luciferase reporter assays using a single effector plasmid showed that the UL3 gene is strongly trans-activated by only the IEP, but not by any other EHV-1 regulatory protein ( Fig. 2A) . Assays in which pairs of EHV-1 regulatory proteins were tested for the ability to trans-activate the UL3 promoter revealed that none of the proteins acted synergistically to achieve promoter activity greater than that obtained by the IEP alone (Fig. 2B) . Overall, the results in Fig. 2B were very similar to those obtained with other EHV-1 promoters in that the negative IR2 protein greatly inhibited trans-activation mediated by the IEP (Kim et al., 2006) and that the EICP0P exhibited Fig. 1 . The genomic location of the UL3 gene, UL3 reporter constructs, and the UL3 promoter activities. (A) The location of the UL3 gene in the EHV-1 UL region. The RacL11 EHV-1 genome lacks a part of the UL1 gene and the entire UL2 gene compared to that of Ab4 EHV-1. The numbers indicate the nucleotide distances in the EHV-1 genome based on the Ab4 EHV-1 sequence. (B) The UL3 cis-acting elements and UL3 promoter regions cloned into pGL3-Basic vector for promoter assay. "+" and "−" indicate the nucleotide distance from the UL3 transcription initiation site (Tci) (+1). Different regions of the UL3 promoter were cloned into the pGL3-Basic vector (Promega) as described in Materials and methods. (C) The promoter activities from the different promoter regions of the UL3 gene without the effector vector. RLU (relative luciferase unit). Error bars indicate the standard deviation.
an antagonistic effect on the IEP-mediated trans-activation of the UL3 promoter (Kim et al., 2003) .
The EHV-1 UL3 is an early gene and encodes a tegument protein An earlier study showed that UL3 is transcribed as a 1.2 kb polyadenylated RNA and mapped its transcription start site and termination site, but assignment of the UL3 gene to a temporal class was not carried out. To this end, the UL3 RNA transcript was examined in EHV-1 infected RK13 cells treated with metabolic inhibitors, and RNA transcripts representative of the immediate-early (IE), early (TK) and late (gK) temporal classes were detected as controls. When protein synthesis was inhibited by the addition of cycloheximide (CHX), the sole IE RNA transcript, but not the UL3, early TK, or late gK transcripts, was readily detected at 6 hours post infection (hpi) (Fig. 3A lane 3) . In uninhibited infected cells, the UL3, IE and TK transcripts were present at 6 hpi, but the late gK RNA was not detected. When EHV-1 infected cells were treated with the viral DNA replication inhibitor phosphonoacetic acid (PAA), RNA transcripts of the immediate-early gene, early TK gene, and the UL3 gene were detected at 20 hpi ( Fig. 3A lane 5) , but the true late gK transcript was not synthesized as expected. Transcripts of all three gene classes were readily detected at 20 hpi in cells not treated with inhibitors. Overall, these results clearly indicate that the UL3 gene is a member of the early temporal class.
The UL3 gene encodes a protein with a predicted size of 258 amino acids that is detected in the perinuclear region of infected cells (Harty et al., 1993a) . A~33 kDa UL3P was detected in cells transfected with a UL3 ORF-expressing plasmid (Fig. 3B lane 3) and in cells infected with RacL11 (Fig. 3B, lane 5) , but not in mock-infected cells (Fig. 3B lane 2) . In addition, a~60 kDa GFP-UL3 fusion protein was detected in cells transfected with a plasmid expressing the GFP-UL3 fusion gene (Fig. 3B, lane 4) , confirming that the UL3 gene encodes~33 kDa UL3P during EHV-1 infection. Additional analysis to examine whether the UL3P is a structural protein showed that the~33 kDa UL3P was detected in purified EHV-1 virions (Fig. 4A, lane 4) and infected RK13 cells (Fig. 4A, lane 3) , but not in mock-infected cells (Fig. 4A , lane 2).
To address the location of the UL3P within the EHV-1 virion, NP-40 treated purified virions were fractionated using a 15-50% sucrose gradient, and each fraction was assayed for the UL3 protein. Both the UL3P and the well characterized ETIF tegument protein were detected in the same bottom fraction (Fig. 4B , fraction 1) which is the nucleocapsid/tegumentenriched fraction as shown previously (Lewis et al., 1997) . The UL3P was also detected in the top fraction which is the envelope-enriched fraction (Fig. 4B) , suggesting the possibility that the UL3P may be an envelope protein. To exclude this possibility, immunofluorescence staining assays were performed using formalin fixed EHV-1 infected RK13 cells and antibodies to UL3P and EHV-1 glycoprotein D (anti-gDP) as described in Materials and methods. If the UL3P were a viral envelope protein, the UL3P would be expressed on the surface of the EHV-1 infected RK13 cell at late times after infection and would be detected by immunofluorescence staining. Anti-glycoprotein D antibodies detected the EHV-1 gD envelope protein on the surface of EHV-1 infected RK13 cells as a positive control (Fig. 4C, c and d ), but not on mock-infected cells (Fig. 4C, a and b) . The UL3P was not detected either on surface-stained mock-infected RK13 cells (Fig. 4D, a and b) or EHV-1 infected RK13 cells (Fig. 4D, c and d) . To rule out the possibility that the failure to detect the UL3P on the cell surface may be due to poor expression of the UL3P or the inability of the anti-UL3P antibody to bind to native UL3P, western blot analysis of infected cell extracts and immunofluorescence staining of permeabilized infected RK13 cells were performed, respectively. The UL3P was readily detected in infected RK13 cells, but not in mockinfected RK13 cells (data not shown). In addition, anti-UL3P antibodies detected the UL3P in permeabilized EHV-1 infected RK13 cells (Fig. 4E , c and d), but not in permeabilized mock-infected RK13 cells (Fig. 4E, a  and b) . These results indicate that the UL3P is a tegument protein and also suggest that the UL3P may be associated with envelope protein(s) of the EHV-1 virion.
The UL3 gene is dispensable for EHV-1 replication
To determine whether the UL3 gene is essential for EHV-1 replication, we constructed a UL3 gene deleted EHV-1 (vL11ΔUL3) by using the GalK BAC technology as described in Materials and methods (Warming et al., 2005) . The replacement of the UL3 gene with the GalK marker was confirmed by PCR amplification of the GalK marker flanking sequence. The expected sizes of left (Fig. 5C , P1 and P3 primer set) and right (Fig. 5C , P2 and P4 primer set) flanking regions were PCR-amplified from pL11ΔUL3-GalK (Fig. 5A , lanes 1 and 3), but not from pRacL11 (Fig. 5A , lanes 2 and 4). DNA sequence analysis of the PCR amplicons (data not shown) indicated that the UL3 gene was completely replaced with the GalK marker. Next, to exclude the possibility that the GalK marker may affect the biology of the mutant virus, the GalK marker of pL11ΔUL3-GalK was removed to construct a UL3 deleted BAC plasmid (pL11ΔUL3). Also, the GalK insert was replaced with the UL3 gene to construct a UL3 rescued BAC plasmid (pL11ΔUL3R). As shown in Fig. 5B , a primer set (Fig. 5C , P5 and P2) specific to the UL3 gene flanking regions generated amplicons of the expected sizes from the pL11ΔUL3-GalK (Fig. 5B , lane 1), pL11ΔUL3 (Fig. 5B , lane 2), and pL11ΔUL3R (Fig. 5B, lane 3) . DNA sequence analysis of each of the amplicons validated the nature of each construct (data not shown). Further, the deletion and rescue of the UL3 gene were confirmed by the BamHI digestion pattern and Southern blot analyses. The BamHI digestion showed that the digestion pattern of pL11ΔUL3-GalK (Fig. 6A , lane 2) and pL11ΔUL3 (Fig. 6A , lane 3) differed from those of pRacL11 (Fig. 6A , lane 1) and pL11ΔUL3R ( Fig. 6A , lane 4). Southern blot analyses using the BamHI digested DNAs and probes specific to the UL3 gene and to the GalK marker showed that the UL3 gene specific probe bound only to pRacL11 (Fig. 6B , lane 1) and pL11ΔUL3R (Fig. 6B, lane 4) , but not to pL11ΔUL3-GalK and pL11ΔUL3 (Fig. 6B , lanes 2 and 3, respectively), and that the GalK marker specific probe bound only to pL11ΔUL3-GalK (Fig. 6C , lane 2), but not to pRacL11, pL11ΔUL3, and pL11ΔUL3R ( Fig. 6C , lanes 1, 3, and 4, respectively). These results indicate that the UL3 gene of pRacL11 was replaced with the GalK marker and that the GalK marker was removed from pL11ΔUL3-GalK and replaced with the UL3 gene. Once the UL3 gene was deleted from pRacL11 and recovered from the pL11ΔUL3-GalK, the UL3 null virus (vL11ΔUL3) and UL3 rescued virus (vL11ΔUL3R) were generated by cotransfection of pL11ΔUL3 or pL11ΔUL3R, respectively, and the Us4 gene containing plasmid into RK13 cells as described in Materials and methods. The absence of the UL3 gene in vL11ΔUL3 and recovery of the UL3 gene in vL11ΔUL3R were confirmed by western blot analysis using an anti-UL3P antibody. The anti-UL3P antibody detected ã 33 kDa UL3P in RK13 cells infected with RacL11 (Fig. 6D , lane 2) and vL11ΔUL3R (Fig. 6D, lane 5) . Also, a~60 kDa GFP-UL3 fusion protein as a control was detected from the pGFP-UL3 plasmid transfected RK13 cells (Fig. 6D, lane 4) . However, the~33 kDa UL3P was not detected in RK13 cells infected with vL11ΔUL3 (Fig. 6D, lane 3) , indicating that the UL3 gene was successfully removed and that the UL3 gene is not essential for the EHV-1 replication. The levels of IEP expression during the course of infection were virtually identical in Fig. 5 . Confirmation of the deletion of the UL3 gene by PCR analysis. The replacement of the UL3 gene with the GalK marker and removal of the GalK marker were verified by PCR amplification of the UL3 flanking sequences by using primer sets specific to the UL3 flanking region sequences as described in Materials and methods. (A) PCR amplification of the UL3 flanking region to confirm replacement of the pRacL11 UL3 gene with the GalK marker. Primer sets were specific to the GalK marker and the UL3 flanking region sequences, respectively. Left flanking region (lanes 1 and 2). Right flanking region (lanes 3 and 4). (B) The PCR amplification of the UL3 flanking regions to confirm removal of the GalK marker from the pL11ΔUL3-GalK and the recovery of the UL3 gene in pL11 ΔUL3R. The primer set was specific to the UL3 flanking region sequences. (C) The location of primers on GalK marker and UL3 flanking regions. P and arrows indicate primer and primer directions, respectively. cells infected with the parental and revertant viruses, indicating that deletion and repair of the UL3 gene was successful without major alteration of genomic structure.
The vL11ΔUL3 exhibits host cell tropism, plaque size, and growth kinetics similar to those of the parental virus Next, the plaque morphology of vL11ΔUL3 on RK13 cell monolayers was examined. As shown in Fig. 7 , the RacL11, vL11ΔUL3R, and vL11ΔUL3 showed similar plaque morphology on RK13 cell monolayers (Figs. 7A and B) , and there was no significant difference in plaque size among the three viruses (each p value N 0.266). To assess if the deletion of UL3 affected host range, the ability of vL11ΔUL3 to replicate in LM, RK13, NBL-6, Vero, and HeLa cells was examined. The vL11ΔUL3, like both the parental virus and the UL3 revertant virus, was able to grow in cells of mouse, rabbit, equine, monkey, and human origin and replicated in all five cell types to maximal titers that were similar to those of the parental and revertant viruses (Fig. 8A) . In addition, RacL11, vL11ΔUL3, and vL11ΔUL3R exhibited similar growth kinetics in RK13 cells infected with viruses at moi of 2 or 0.2 (Fig. 8B) , indicating that the deletion of the UL3 gene does not affect the growth properties of EHV-1 in cell culture.
Deletion of the UL3 gene does not alter the EHV-1 gene program
Even though the vL11ΔUL3 lacking the UL3 gene showed host cell tropism and growth kinetics similar to those of the parental virus, the possibility existed that deletion of the UL3 gene may affect the EHV-1 gene program. To address this possibility, the expression of the EHV-1 sole IE gene and representative early and late genes at different time points of infection was compared in RK13 cells infected with parental RacL11 virus and vL11ΔUL3. The IEP was detected at 3 hpi in both RacL11 and vL11ΔUL3 infected RK13 cells, and IEP levels in both RacL11 and vL11ΔUL3 infected cells were almost identical during early and late stages of replication (Fig. 9A, panel a) . Protein expression from three early regulatory genes (UL5, IR4, and EICP0) was barely detected in RK13 cells infected with RacL11 or vL11ΔUL3 at 3 hpi, and the levels of these three proteins in both RacL11 and vL11ΔUL3 infected cells were similar during early and late time points of replication (Fig. 9A, panels b, c, and d) . As expected, the late gene product glycoprotein D was first detected at 12 hpi (Fig. 9A panel e, lanes 7 and 8) , and the amount of gD in RacL11 and vL11ΔUL3 infected RK13 cells was similar. These results and those of repeated experiments that yielded results virtually identical to those in Fig. 9 suggest that the absence of the UL3 gene does not affect the EHV-1 gene program in its transition from the immediateearly to early to late stages.
UL3 is not essential for EHV-1 replication or virulence in the CBA mouse model
To examine if the deletion of the UL3 gene affects EHV-1 replication or virulence in vivo, experiments in the well characterized CBA model were performed as described in Materials and methods. As shown in Fig. 10A , mice infected intranasally with vL11ΔUL3 exhibited a rapid and major loss in body identical to losses observed in animals infected with the highly pathogenic parental RacL11 or UL3 revertant virus, and all infected animals exhibited clinical signs of lethargy, huddling, and ruffled fur. By three days post infection, loss of total body weight for the three groups of infected mice was 25%, and comparison of body weight to that of the uninfected mice showed p values of b0.00001. There were no significant differences of body weight loss among the groups of mice infected with RacL11, vL11ΔUL3, and vL11ΔUL3R (all p values N 0.28). When considering mortality of EHV-1 infected mice, mice infected with vL11ΔUL3 began to die rapidly as 6 of 9 infected mice died by 3 dpi, and all 9 Comparison of the expression of EHV-1 immediate early, early, and late proteins in RK13 cells was performed by western blot analyses as described in Materials and methods. Lane 1 is a protein marker, lane 2 is a mock-infected RK13 cell control, lanes 3, 5 and 7 are RacL11 infected RK13 cells, and lanes 4, 6 and 8 are vL11ΔUL3 infected RK13 cells. GAPDH was used as the control protein. Panels "a" to "e" indicate the immediate early protein, early UL5 protein, early IR4 protein, early EICP0 protein, and late glycoprotein D, respectively. mice (100%) in this group succumbed by 4 dpi (Fig. 10B) . Four of 9 mice infected with RacL11 died at 3 dpi, and 7 of the 9 (77%) mice died by 7 dpi. Two of 9 mice infected with vL11ΔUL3R died at 3 dpi, and 8 of the 9 (88%) mice died by 7 dpi. Also, percent survival data of mice infected with vL11ΔUL3 was not significantly different from those of mice infected with RacL11 or vL11ΔUL3R (p values N 0.31). To determine whether the viral load differed among the three groups of infected mice, viral titers in the lungs harvested from live and dead mice were examined. The viral titers of lungs harvested from live mice at days 2, 3, and 4 post infection were similar among the three groups (Fig. 10C) , and the viral titers of lungs of mice that succumbed to infection also did not differ among the groups (Fig. 10D) . Overall, the results of all animal experiments revealed that the UL3 gene is not required for EHV-1 replication or virulence in the CBA mouse model.
Discussion
The EHV-1 UL3 gene that encodes a~33 kDa myristylated cytoplasmic protein (Harty et al., 1993a ) is one of only three genes that comprise the genome of EHV-1 defective interfering particles (DIP) that mediate EHV-1 persistent infection (Chen et al., 1996 (Chen et al., , 1999 Ebner and O'Callaghan, 2006; Ebner et al., 2008; Harty et al., 1993b) . The IE protein encoded by the standard virus present in EHV-1 preparations enriched for DIP activates expression of the three DIP genes, UL3, UL4, and IR4/UL5 hybrid, resulting in high levels of the UL3, UL4 and hybrid proteins that mediate interference with standard virus replication. Studies with recombinant DIP that replicate faithfully and can mediate persistent infection revealed the specific domains of the hybrid protein that are important for DIP interference activity (Ebner et al., 2008) . Deletion of the UL3 gene that is perfectly conserved in the DIP genome leads to a markedly reduced ability of the DIP to interfere with standard virus replication in cell culture (Ebner et al., 2008) . As discussed below, the UL3 protein downregulates EHV-1 promoters, an observation consistent with the finding that high level expression of UL3 in DIP-infected cells leads to reduction in standard virus replication. Also, recent experiments to characterize the properties of the UL4 gene have shown that the early UL4 protein can enter the nucleus and has a broad inhibitory function, suggesting its potential role in DIP-mediated interference and/or persistent infection (Charvat et al., 2011) .
These recent observations about the UL4 gene suggest the possibility that the poorly characterized UL3 gene may play a role in EHV-1 gene regulation and contribute to the biological functions of EHV-1 DIP. Here, we initiated studies to define basic aspects of the regulation and expression of the UL3 gene and showed that its expression is governed by the sole IE protein and that experiments with metabolic inhibitors definitively assigned UL3 to the early gene class. Western blot analysis using purified EHV-1 virions revealed that the UL3P is a component of the EHV-1 virion, and detection of the UL3P from both the soluble material and insoluble pellet of EHV-1 infected cells (data not shown) suggests that the UL3P is readily solubilized. A similar observation that the circ protein of bovine herpesvirus 1, the UL3P homologue, is a virion component was reported by Fraefel et al. (1994) . Fractionation of highly purified EHV-1 virions revealed that the UL3P colocalized with the ETIF protein, suggesting that the UL3 protein is a tegument component. However, following sucrose gradient fractionation of NP-40 disrupted virions, a significant portion of the UL3P was also detected in the enveloperich top fraction, but the UL3P was not detected on the surface of EHV-1 infected RK13 cells by immunofluorescence staining. In addition, plaque reduction assays revealed that anti-UL3P antibody could not neutralize EHV-1 (data not shown). These results and the fact that the protein is myristylated may indicate that the UL3P lies within the outer portion of the tegument such that it associates with envelope protein(s), but the UL3P is not an envelope protein.
Examination of the growth properties of an UL3 null virus (vL11ΔUL3) generated by BAC technology clearly showed that the UL3 gene is dispensable for EHV-1 replication in cell culture and that UL3 does not contribute to the broad host range of this equine pathogen. The UL3 deleted virus like the parental and UL3 revertant viruses was capable of high titer replication in cells of mouse, rabbit, equine, primate, and human origin. The UL3 null virus was also capable of high titer replication in the CBA mouse model and exhibited pathogenic properties of the parent virus such that 100% of mice infected with VL11ΔUL3 succumbed to infection by 4 days post infection. Thus, EHV-1 deleted of UL3 exhibited many of the biological properties of the recently characterized UL4 null virus (Charvat et al., 2011) , indicating that these two genes that are conserved in the DIP genome do not contribute functions essential for EHV-1 growth in cell culture or pathogenicity in the mouse model, even though we cannot exclude the possibility that the UL3 gene may play a role in EHV-1 infection of the horse. Unexpectedly, luciferase reporter assays employing a variety of EHV-1 promoters and heterologous promoters of other viruses and cellular genes showed that the UL4 protein has a broad inhibitory function (Charvat et al., 2011 ) that may be due to its ability to bind some cellular general transcription factors. Ongoing experiments employing similar reporter assays have also shown that the UL3P downregulates luciferase activity under the control of either EHV-1 promoters or promoters of cellular genes. Also, preliminary findings from in vitro protein-protein interactive assays revealed that the UL3P binds cellular TATA box binding protein (TBP) in an in vitro interaction assay (unpublished data). These preliminary data suggest that both the UL3 and UL4 proteins contribute functions that may temper EHV-1 gene expression and contribute to the ability of defective interfering particles to interfere with standard virus such that persistent infection can develop. Whether these functions mediated in vitro by the UL3P are essential aspects of DIP mediated persistent infection is a topic now under investigation in our laboratory.
Materials and methods
Cell culture and viruses
The LM, RK13, equine NBL-6, Vero, and HeLa cells used for viral propagation were maintained with Eagle's minimal medium supplemented with 100 units of penicillin/ml, 100 μg of streptomycin/ml, nonessential amino acids, and 5% (or 10%) fetal bovine serum. Pathogenic RacL11 EHV-1 was used as the wild type EHV-1 (Hubert et al., 1996) .
Purification and fractionation of EHV-1 virions
Highly purified EHV-1 virions were prepared according to previous methods (O'Callaghan and Randall, 1976; Perdue et al., 1974) and fractionated using a modified method of Murphy et al. (2008) . 100 μl of purified EHV-1 virions were mixed with 1 μl NP-40 followed by incubation at 4°C for 30 min. NP-40 treated virions were placed on the top of a microfuge tube that contains 500 μl of 50% sucrose in the bottom and then 500 μl of 15% sucrose on the top followed by centrifugation at 14 K rpm at 4°C for 2 h. Five 200 μl fractions were collected from the top to the bottom, and the presence of the UL3P in each fraction was assessed by western blot analysis.
Construction of plasmids
PCR products were amplified using Accuprime pfx polymerase (Invitrogen, Carlsbad, CA), pRacL11 EHV-1 BAC (pRacL11) template, and proper primers. PCR products were digested with appropriate restriction enzymes and cloned into proper vectors using standard cloning methods (Sambrook et al., 1989) . All clones were confirmed by sequence analysis. Primer designs were based on the published sequences Telford et al., 1992) . The PCR product of the UL3 ORF (primers, 5′ ttt gaa ttc gcc acc atg ggg gcc tgc tgc tcc tct ag 3′, 5′ tta tgt aca att cag acc gta tat ggt gtt ttg c 3′) was digested with EcoRI and BsrGI, and cloned into pEGFP-N1 (BD Biosciences, San Jose, CA) digested with EcoRI and BsrGI (named pCMV-UL3). For the GFP-UL3 fusion gene construction, the PCR product of the UL3 gene (primers, 5′ ttt ctg tac aag acg cgt atg ggg gcc tgc tgc tcc tct aga cgc 3′, 5′ ttt gcg gcc gct act agt att cag acc gta tat ggt gtt ttg c 3′) was digested with BsrGI and NotI, and cloned into pEGFP-N1 (BD Bioscience) digested with BsrGI and NotI (named pGFP-UL3). To characterize the promoter of the UL3 gene, the UL3 promoter region was PCR-amplified. PCR products of UL3 (−777/+324) (primers, 5′ tta ggt acc act gct atg ctg ggg ctc act g 3′, 5′ tat aga tct tag tac gtg cgt cac acc g 3′), UL3(−777/+225) (primers, tta ggt acc act gct atg ctg ggg ctc act g 3′, 5′ tta aga tct atg ttg gtt aca ggg gtg 3′), UL3(−342/+324) (primers, 5′ ata ggt acc aca cag tct ttt aac acc atg 3′, 5′ tta aga tct atg ttg gtt aca ggg gtg 3′), and UL3(− 777/−54) (primers, 5′ tta ggt acc act gct atg ctg ggg ctc act g 3′, 5′ tta aga tct agg agc cca atg gaa aaa ag 3′) were digested with KpnI and BglII, and then cloned into pGL3-Basic (Promega, Madison, WI) digested with KpnI and BglII, respectively (named pUL3 (−777/+324)-Luc, pUL3(− 777/+225)-Luc, pUL3(−342/+324)-Luc, and pUL3(−777/−54)-Luc).
Luciferase reporter assays
Luciferase reporter assays were performed as previously described (Ahn et al., 2007) . Briefly, 80% confluent RK13 cells were prepared in 24 well plates, and 0.5 pM of reporter vector and 1 pM of effector vector were used for cotransfection. Reporter vectors were pUL3(−777/ +324)-Luc, pUL3(−777/+225)-Luc, pUL3(−342/+324)-Luc, and pUL3(−777/−54)-Luc. The effector vectors expressing EHV-1 regulatory proteins were pIE, pIR2, pEICP0, pIR4, pUL5, and pETIF (Ahn et al., 2007) as well as pCMV-UL3. Six micro litters of lipofectin (Invitrogen) were mixed with 100 μl of Opti-MEM medium (Gibco, BRL, Gaithersburg, MD), and incubated for 45 min at room temperature. Effector and reporter plasmids were mixed with 100 μl of Opti-MEM medium (Gibco, BRL), and total DNAs were adjusted to the same amount with the pSVSPORT1 DNA (Gibco, BRL). The mixture was combined and incubated at room temperature for 15 min, and 460 μl of Opti-MEM medium (Gibco, BRL) was added. One-third of the total mixture was transferred into each of three wells of a 24 well plate of RK13 cells after washing with serumand antibiotics-free E-MEM. At 8 hours post transfection (hpt), normal growth medium was added, and luciferase activities were measured at 48 hpt using a luciferase assay kit (Promega) and a POLARstar OPTIMA plate reader (BMG LABTECH Inc., Cary, NC) according to the manufacturer's directions.
Metabolic inhibitor treatment of EHV-1 infected RK13 cells and isolation of RNA transcripts
Metabolic inhibition in virus-infected RK13 cells was performed as previously described (Caughman et al., 1985; Gray et al., 1987b; Charvat et al., 2011) . Briefly, 85% confluent RK13 cells were infected with EHV-1 at moi of 5 and incubated at 37°C in the presence of the protein synthesis inhibitor cycloheximide (CHX, 100 μg/ml) (Sigma-Aldrich Corp. St. Louis, MO) for 6 hours, or in the presence of the viral DNA replication inhibitor phosphonoacetic acid (PAA, 200 μg/ml) (Sigma-Aldrich Corp.) for 20 h followed by isolation of total RNA using a RNA Easy Kit (Qiagen, Valencia, CA). RNA transcripts were detected by northern blot assays using total RNA and probes specific to each RNA transcript.
Immunofluorescence staining 90% confluent RK13 cells were mock infected or infected with EHV-1 at moi of 5 for 2 h at 4°C, and incubated at 37°C for 3 h. The cells were trypsinized and split into a 6 well plate including a cover slide at each well followed by additional 6 hours incubation. RK13 cells were fixed with 4% paraformaldehyde/PBS for 20 min or 0.2% Triton X 100 for 5 min and washed with PBS. Goat serum (SigmaAldrich, 1:100 dilution in PBS) was added, and the slides were incubated at 37°C for 1 h followed by five PBS washes for 5 min each. Primary antibodies [anti-UL3P or anti-gDP antibodies (1:100 in PBS)] were added onto goat serum treated RK13 cells and incubated at 37°C for 1 h followed by five PBS washes for 5 min each. An anti-rabbit IgG FITC conjugate (Sigma-Aldrich, 1:100 dilution in PBS) was added, and the slides were incubated at 37°C for 1 h followed by five PBS washes. The slides were viewed on a Nikon Eclipse TE300 fluorescent microscope (Melville, NY).
Generation of vL11ΔIR3
To construct a vL11ΔUL3 lacking the UL3 gene, GalK BAC technology was used as previously described (Ahn et al., 2010; Warming et al., 2005) . The plasmid pRacL11 EHV-1 BAC (named pRacL11) (Rudolph et al., 2002) was transformed into SW106 E. coli. The purified PCR product of the GalK marker harboring the EHV-1 UL3 gene flanking sequence (primers, 5′ agg ttt ccg ccg tgc ctg gtg tcg agg gcc cac ccc tgt aac caa cat cg/cct gtt gac aat taa tca tcg gca 3′/5′ cgc cag cga gaa aat aaa cga taa att cag acc gta tat ggt gtt ttg ctt ttt att taa/tca gca ctg tcc tgc tcc tt 3′) was transformed into SW106 cells containing the pRacL11. Positive colonies were selected on Gal positive selection agar plates and confirmed by PCR amplification (primers, 5′ tga aac atc tgc aac tgc gta aca aca gct tcg g 3′/5′ gtt aca gca gcg act gca agc tgg 3′; 5′ atg atc ccg cag tta cag cct aca aac tgg 3′/5′ att ggt acc tcc gat cag cac cag aat ctg 3′) of the EHV-1 UL3 gene flanking regions (named pL11ΔUL3-GalK). To remove the GalK marker from pL11ΔUL3-GalK, counter selection was performed. Both flanking regions of the UL3 gene were combined by multiple rounds of PCR amplification (left flanking region primers, 5′ cta act tta ctc aac caa caa ccc tgg 3′/5′ atg ata ctg acg atg ttg gtt aca ggg gtg ggc 3′; right flanking region primers, 5′ cgt cag tat cat aag caa aac acc ata tac ggt ctg 3′/5′ gtt aca gca gcg act gca agc tgg 3′, combined flanking region primers, 5′ cta act tta ctc aac caa caa ccc tgg 3′/5′ gtt aca gca gcg act gca agc tgg 3′). The purified UL3 flanking region PCR DNA was transfected into SW106 cells containing the pL11ΔUL3-GalK and positive colonies were selected on Gal counter selection plates. Positive colonies (named pL11ΔUL3) were confirmed by PCR amplification (primers, 5′ gtt aca gca gcg act gca agc tgg 3′/5′ tta ggt acc act gct atg ctg ggg ctc act g 3′), sequence analysis of amplified PCR amplicons, BamHI digestion, and southern blot analysis. To generate EHV-1 lacking the UL3 gene, the purified pL11ΔUL3 and the Us4 gene containing plasmid were co-transfected into 80% confluent RK13 cells by using a BD CalPhos Mammalian transfection kit (Clontech, Mountain View, CA) according to the manufacturer's directions. Supernatants were harvested at 3 days post transfection (dpt), and the mutant virus was screened by plaque purification. Plaques lacking green fluorescence were selected and purified by three rounds of plaque assays (named vL11ΔUL3). To generate the UL3 gene rescued EHV-1 from pL11ΔUL3-GalK, the PCR product harboring the UL3 gene and its flanking sequences (primers, 5′ gtt aca gca gcg act gca agc tgg 3′/5′ cta act tta ctc aac caa caa ccc tgg 3′) was transfected into SW106 E. coli harboring pL11ΔUL3-GalK. The replacement of the GalK marker with the UL3 gene was confirmed, and the UL3 gene rescued EHV-1 was generated (named vL11ΔUL3R) as described above.
Southern, northern, and western blot analyses
To confirm replacement of the UL3 gene of pRacL11 with the GalK marker, removal of the GalK marker of pL11ΔUL3-GalK, and replacement of the GalK marker of pL11ΔUL3-GalK with the UL3 gene, BamHI digested pRacL11, pL11ΔUL3-GalK, pL11ΔUL3 and pL11ΔUL3R DNAs were separated on a 0.3% agarose gel, and transferred onto a positively charged nylon membrane (Ambion, Austin, TX) by using a semi-dry electroblotter (Bio-Rad Laboratories, Hercules, CA). The DNA transferred membrane was placed on a piece of blot paper saturated with 0.5 M NaOH for 15 min, briefly washed with 2 × SSC, and baked at 80°C for 1 h. The PCR amplicon of the GalK marker (primers, 5′ cct gtt gac aat taa tca tcg gca tag 3′/5′ act gtc ctg ctc ctt gtg atg g 3′) and the UL3 gene (primers, 5′ aca aaa tta cct acg cca act ctg cga acg 3′/5′ gct tct gcg tag att tga taa cct cag agg 3′) were end-labeled with [γ-32 P]ATP (New England Nuclear Corporation, Boston, MA) by T4 polynucleotide kinase (Promega) according to the manufacturer's directions, respectively. The radiolabeled probe was denatured by adding 1/10 volume of 3 M NaOH for 10 min at room temperature and then neutralized by adding an equal volume of 1 M Tris-HCl (pH 7). Prehybridization, hybridization, and washing were performed using the NorthernMax Kit (Ambion) followed by autoradiography using a phosphor image screen and the molecular imager FX system (Bio-Rad Laboratories).
To detect the RNA transcripts of the UL3, IE, gK and TK genes, total RNAs from metabolic inhibitor treated RK13 cells were separated on 5% urea gels and transferred onto a positively charged nylon membrane (Ambion, Austin, TX) by using a semi-dry electroblotter (BioRad Laboratories) followed by baking of the RNA transferred membrane at 80°C for 1 h. Probes specific to RNA transcripts were prepared from the PCR amplicons of the UL3 gene (primers, 5′ aca aaa tta cct acg cca act ctg cga acg 3′/5′ gct tct gcg tag att tga taa cct cag agg 3′), IE gene (primers, 5′ ctc tac gac ttc atc gag agc aac gac ttc 3′/5′ tcg ggc ctc tcc agc gtc ttg gcc aga ttg 3′), gK gene (primers, 5′ tta gga cga gaa gga ctc gcc caa taa gcc 3′/5′ cct atg ccg cgt tta cct tct ggt ata ccc 3′) and TK gene (primers, 5′ gcc ggt cag gcg gca agt aac aat agt tag 3′/5′ gag ggt gct gct cat gag ggg tat tag aga 3′), and the northern blot was performed as described above.
For protein detection, 90% confluent RK13 cells were infected with RacL11, vL11ΔUL3, or vL11ΔUL3R at moi of 10, and virus-infected RK13 cells were harvested at 3, 6, and 12 hpi. pCMV-UL3 and pGFP-UL3 plasmids were transfected into the 90% confluent RK13 cells by using Lipofectin (Invitrogen) according to the manufacturer's directions, and plasmid transfected cells were harvested at 24 hpt. Whole cell lysates of virus-infected and plasmid transfected cells were separated by SDS-PAGE and then transferred to a nitrocellulose membrane (Ambion) by using a semi-dry electroblotter and molecular weight markers (Bio-Rad Laboratories). The immediate-early (IE), early (IR4, EICP0, UL3, and UL5) and late (gD and ETIF) proteins were detected by using anti-EHV-1 protein rabbit polyclonal antibodies (Bowles et al., 1997; Caughman et al., 1995; Flowers and O'Callaghan, 1992; Harty et al., 1993a; Holden et al., 1994; Lewis et al., 1997; Zhao et al., 1995) as primary antibodies and an anti-rabbit IgG[Fc]-alkaline phosphatase conjugate (Promega) as a secondary antibody. Proteins were visualized by incubating the membrane containing blotted proteins in the AP conjugate substrate (AP conjugate substrate kit, Bio-Rad Laboratories) according to manufacturer's directions.
Determination of plaque morphology, cell tropism, and virus growth kinetics
For plaque assays, 90% confluent RK13 cells in 6 well plates were infected with serial dilutions of RacL11, vL11ΔUL3, or vL11ΔUL3R. After 1 hour attachment at 4°C, virus-infected cells were covered with medium containing 1.5% methylcellulose and incubated in 5% CO 2 at 37°C. At 4 dpi, plaques were fixed with 10% formalin, stained with 0.5% crystal violet, and counted (Perdue et al., 1974) . Plaque sizes of RacL11, vL11ΔUL3 or vL11ΔUL3R were measured by using an ImageJ software program (NIH, http://rsbweb.nih.gov/ij/). For single step growth kinetics, 90% confluent RK13 cells in 25 mm 2 flask were infected with RacL11, vL11ΔUL3 or vL11ΔUL3R at moi of 0.2 or 2. After 1 h of viral attachment at 4°C, virus-infected RK13 cells were washed with PBS, and then 4 ml of growth medium was added. Cells and supernatant were harvested at designated time points. Intracellular virus was released by a freeze and thaw cycle, and samples were titered as described above. To determine the cell tropism of vL11ΔUL3, LM, RK13, NBL-6, Vero, and HeLa cells were infected with RacL11, vL11ΔUL3 or vL11ΔUL3R at moi of 5. After 1 h of virus attachment at 4°C, virusinfected cells were washed with PBS followed by adding normal growth medium, and total viral titers were examined at 3 dpi.
Animal experiments and statistical analysis
Animal experiments were conducted as described previously Charvat et al., 2011; Osterrieder et al., 1996; von Einem et al., 2004) . Groups (n=12 for mock infected, n=12 for vL11ΔUL3, n=12 for vL11ΔUL3R, and n=12 for RacL11) of four-week-old CBA mice were intranasally inoculated with 3 ×10 6 pfu of vL11ΔUL3, vL11ΔULR, RacL11, or sterile medium as a mock infection. Mice were observed daily for clinical signs and weighed from prior to inoculation until 7 days post infection. Isolation of virus from lungs of dead or live mice was performed by using silica Beads and a BeadBeater (BioSpec Products, Inc., Bartlesville, OK) according to the manufacturer's directions, followed by viral titration as described above. Viruses were isolated from each group of live mice infected with the RacL11 (n=3), vL11ΔUL3R (n=3), or vL11ΔUL3 (n=3) at 2, 3 and 4 dpi, and virus isolation from lungs of the dead mice was performed at the time of death. For the statistical analysis to compare the body weight of mice between two groups and plaque sizes of viruses, the two-tailed Student's t-test was performed by using an excel software program (Microsoft Corporation, Redman, WA). Significance of the percent survival to judge virulence was determined by the Log-rank (Mantel-Cox) test using GraphPad Prism software (GraphPad software, Inc., La Jolla, CA).
